NEW DELHI : The Directorate General of Foreign Trade (DGFT) on Friday lifted restrictions on export of formulations made of paracetamol, including fixed dose combinations of the drug, but continued to bar export of the active pharmaceutical ingredient (API) itself following concern of shortages from China.
The move follows assurances by the Indian industry that it has the manufacturing prowess in formulations to maintain stocks of the drug. “We have adequate quantity of paracetamol formulations.
Also, with paracetamol, unlike the other APIs, we have some capacity, but we did not want the export of API to be unregulated.